Bank of America’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $72M | Sell |
1,309,788
-151,514
| -10% | -$6.2M | ﹤0.01% | 1421 |
|
|
2026
Q1 | $48.5M | Buy |
1,461,302
+610,195
| +72% | +$18.2M | ﹤0.01% | 1614 |
|
|
2025
Q4 | $25.4M | Buy |
851,107
+224,454
| +36% | +$7.33M | ﹤0.01% | 2090 |
|
|
2025
Q3 | $22.6M | Buy |
626,653
+59,275
| +10% | +$1.95M | ﹤0.01% | 2507 |
|
|
2025
Q2 | $20.4M | Sell |
567,378
-117,098
| -17% | -$4.36M | ﹤0.01% | 2536 |
|
|
2025
Q1 | $27M | Buy |
684,476
+453,537
| +196% | +$15.3M | ﹤0.01% | 2144 |
|
|
2024
Q4 | $6.95M | Sell |
230,939
-1,466,433
| -86% | -$42.1M | ﹤0.01% | 3278 |
|
|
2024
Q3 | $39.7M | Sell |
1,697,372
-384,516
| -18% | -$8.4M | ﹤0.01% | 1770 |
|
|
2024
Q2 | $37M | Sell |
2,081,888
-119,562
| -5% | -$1.91M | ﹤0.01% | 1696 |
|
|
2024
Q1 | $33.5M | Buy |
2,201,450
+1,618,362
| +278% | +$25.8M | ﹤0.01% | 1802 |
|
|
2023
Q4 | $9.96M | Sell |
583,088
-63,136
| -10% | -$734K | ﹤0.01% | 2897 |
|
|
2023
Q3 | $5.4M | Buy |
646,224
+331,948
| +106% | +$4.63M | ﹤0.01% | 3337 |
|
|
2023
Q2 | $7.81M | Sell |
314,276
-416,250
| -57% | -$10.8M | ﹤0.01% | 2961 |
|
|
2023
Q1 | $11M | Sell |
730,526
-166,524
| -19% | -$2.53M | ﹤0.01% | 2730 |
|
|
2022
Q4 | $10.6M | Sell |
897,050
-76,582
| -8% | -$556K | ﹤0.01% | 2637 |
|
|
2022
Q3 | $5.76M | Buy |
973,632
+162,036
| +20% | +$1.06M | ﹤0.01% | 3193 |
|
|
2022
Q2 | $3.45M | Sell |
811,596
-88,931
| -10% | -$555K | ﹤0.01% | 3778 |
|
|
2022
Q1 | $8.56M | Buy |
900,527
+264,866
| +42% | +$3.07M | ﹤0.01% | 3018 |
|
|
2021
Q4 | $12.1M | Buy |
635,661
+194,084
| +44% | +$5.04M | ﹤0.01% | 2735 |
|
|
2021
Q3 | $14.7M | Sell |
441,577
-42,684
| -9% | -$1.32M | ﹤0.01% | 2461 |
|
|
2021
Q2 | $18.8M | Sell |
484,261
-293,760
| -38% | -$11.5M | ﹤0.01% | 2195 |
|
|
2021
Q1 | $37.5M | Buy |
778,021
+395,027
| +103% | +$19M | ﹤0.01% | 1513 |
|
|
2020
Q4 | $19.9M | Buy |
382,994
+227,573
| +146% | +$7.69M | ﹤0.01% | 1898 |
|
|
2020
Q3 | $4.16M | Buy |
155,421
+34,063
| +28% | +$784K | ﹤0.01% | 3084 |
|
|
2020
Q2 | $2.36M | Buy |
121,358
+14,111
| +13% | +$227K | ﹤0.01% | 3484 |
|
|
2020
Q1 | $1.05M | Buy |
107,247
+59,016
| +122% | +$745K | ﹤0.01% | 3977 |
|
|
2019
Q4 | $535K | Sell |
48,231
-84,009
| -64% | -$639K | ﹤0.01% | 4972 |
|
|
2019
Q3 | $743K | Sell |
132,240
-71,028
| -35% | -$495K | ﹤0.01% | 4783 |
|
|
2019
Q2 | $1.76M | Sell |
203,268
-211,796
| -51% | -$1.6M | ﹤0.01% | 4130 |
|
|
2019
Q1 | $3.34M | Buy |
415,064
+401,634
| +2,991% | +$2.17M | ﹤0.01% | 3549 |
|
|
2018
Q4 | $55K | Sell |
13,430
-584,236
| -98% | -$2.9M | ﹤0.01% | 6176 |
|
|
2018
Q3 | $3.35M | Buy |
597,666
+495,962
| +488% | +$5.67M | ﹤0.01% | 3542 |
|
|
2018
Q2 | $1.34M | Buy |
101,704
+70,070
| +222% | +$964K | ﹤0.01% | 4282 |
|
|
2018
Q1 | $449K | Buy |
31,634
+14,723
| +87% | +$188K | ﹤0.01% | 4895 |
|
|
2017
Q4 | $138K | Buy |
16,911
+6,913
| +69% | +$60.4K | ﹤0.01% | 5591 |
|
|
2017
Q3 | $119K | Buy |
9,998
+4,476
| +81% | +$51K | ﹤0.01% | 5612 |
|
|
2017
Q2 | $55K | Sell |
5,522
-8,554
| -61% | -$95.7K | ﹤0.01% | 5832 |
|
|
2017
Q1 | $164K | Buy |
14,076
+1,395
| +11% | +$10K | ﹤0.01% | 5404 |
|
|
2016
Q4 | $59K | Buy |
12,681
+7,407
| +140% | +$43.4K | ﹤0.01% | 5857 |
|
|
2016
Q3 | $41K | Sell |
5,274
-5,210
| -50% | -$33.5K | ﹤0.01% | 5808 |
|
|
2016
Q2 | $63K | Buy |
10,484
+7,762
| +285% | +$63.1K | ﹤0.01% | 5734 |
|
|
2016
Q1 | $23K | Buy |
2,722
+1,367
| +101% | +$12K | ﹤0.01% | 6087 |
|
|
2015
Q4 | $16K | Buy |
1,355
+545
| +67% | +$6.88K | ﹤0.01% | 6515 |
|
|
2015
Q3 | $8K | Sell |
810
-35,319
| -98% | -$526K | ﹤0.01% | 6647 |
|
|
2015
Q2 | $599K | Buy |
36,129
+33,274
| +1,165% | +$527K | ﹤0.01% | 4555 |
|
|
2015
Q1 | $44K | Buy |
2,855
+2,223
| +352% | +$33.7K | ﹤0.01% | 5719 |
|
|
2014
Q4 | $10K | Sell |
632
-6,400
| -91% | -$83.3K | ﹤0.01% | 7064 |
|
|
2014
Q3 | $75K | Buy |
+7,032
| New | +$65.2K | ﹤0.01% | 6228 |
|
|
2014
Q2 | – | Sell |
-27
| Closed | – | – | 8202 |
|
|
2014
Q1 | $0 | Sell |
27
-506
| -95% | -$3K | ﹤0.01% | 8069 |
|
|
2013
Q4 | $2K | Sell |
533
-7,394
| -93% | -$29.9K | ﹤0.01% | 7647 |
|
|
2013
Q3 | $40K | Sell |
7,927
-16,008
| -67% | -$97.9K | ﹤0.01% | 6548 |
|
|
2013
Q2 | $153K | Buy |
+23,935
| New | +$153K | ﹤0.01% | 5869 |
|
Other funds holding TGTX
SCM
CAM
Bank of America's TGTX Position: Q2 2026 in Review
Bank of America reduced its TG Therapeutics (TGTX) stake by 10% in Q2 2026, selling an estimated $6.2M and leaving 1,309,788 shares worth $72M. The position accounts for ﹤0.01% of the portfolio, ranked #1421.
Bank of America first reported a position in TGTX in Q2 2013 and has held it in 52 quarters since. 427 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.
- Bank of America held 1,309,788 shares of TG Therapeutics worth $72M as of Q2 2026.
- Bank of America sold 151,514 TG Therapeutics shares in Q2 2026, an estimated $6.2M.
- TG Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q2 2026, its #1421 holding.
- Bank of America first reported a position in TG Therapeutics in Q2 2013 and has held it in 52 quarters since.
- 427 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.
Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.